Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment

Clinical trial NCT06666114 · COMPLETED

Trial details

NCT number: NCT06666114
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Psoriasis (PsO)Psoriatic Arthritis (PsA)

Start date: 2021-08-03
Primary completion: 2023-10-10
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.